Becker's Healthcare August 9, 2024
Insurance covers some of the costs for GLP-1 drugs for weight loss for around 1 in 4 Americans, according to data from Leverage and the Robert Wood Johnson Foundation.
Data from Leverage, a consulting firm, accounts for around 89% of insured lives in the U.S.
In five states, more than half of insured individuals have some insurance coverage for new-generation weight-loss drugs, including GLP-1s.
GLP-1 drugs approved for weight loss include Wegovy, Saxenda and Zepbound. The drugs can be expensive, costing more than $1000 a month.
In seven states fewer than 1 in 10 have insurance coverage for new-generation weight-loss drugs, including GLP-1s.
Here is the percentage of insured individuals with coverage for weight loss drugs...
Today's Sponsors
Today's Sponsor